日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors

丙戊酸钠驱动丙酰化介导的表观遗传重编程,从而增强间皮素CAR-T细胞疗法在实体瘤中的疗效

Chen, Jiannan; Li, Wenying; Wang, Shuai; Li, Jiayi; Zhao, Lianfeng; Ao, Xudong; Wang, Wenyu; Zhu, Li; Rao, Haipeng; Xu, Shichu; Wen, Mengru; Hu, Zhigang; Pan, Feiyan; He, Lingfeng; Gu, Lili; Fang, Weijia; Xu, Shengjing; Liang, Junqing; Zhao, Peng; Chen, Haoyan; Guo, Zhigang

AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling.

AGPAT3 通过脂质重塑改变肿瘤细胞对 IFNγ 介导的铁死亡的敏感性,并增强免疫疗法的疗效。

Liu Chuan, Hu Chuan, Cheng Jinlin, Xin Duanfeng, Jin Sujie, Tian Weihong, Li Shan, Jin Yuzhi, Liu Yu, Wu Wei, Hao Shuqiang, Ren Hui, Dai Xiaomeng, Liu Lulu, Ruan Jian, Fang Weijia, Bao Xuanwen, Xin Shan, Zhao Peng

Intra-arterial infusion of bevacizumab for the treatment of peritoneal metastatic high-grade renal cell carcinoma: a case report

动脉内输注贝伐单抗治疗腹膜转移性高级别肾细胞癌:病例报告

Jin, Song; Dai, Chaoming; Dai, Xiaomeng; Zhao, Peng; Zhou, Bin; Zhang, Jizhou; Fang, Weijia

Impact of Early Diagnosis and Immunosuppressive Therapy on Giant Cell Myocarditis Outcomes: A Review

早期诊断和免疫抑制治疗对巨细胞性心肌炎预后的影响:综述

Li, Jie; Fang, Weijia; Qian, Cheng; Yang, Zhi; Kundnani, Nilima Rajpal; Kumar, Abhijit; Sharma, Abhinav; Mihai, Berceanu Vaduva Marcel; Diana Ardelean, Cristina; Marin-Bancila, Lucretia; Valcovici, Mihaela; Levai, Codrina; Iancu, Adela; Rosca, Ciprian Ilie

Neoadjuvant Sintilimab Combined with Gemcitabine and Cisplatin for Muscle-Invasive Bladder Cancer Patients Followed by Selective Bladder Sparing Surgery: A Phase 2 Trial

新辅助信迪利单抗联合吉西他滨和顺铂治疗肌层浸润性膀胱癌患者,随后进行选择性膀胱保留手术:一项 II 期试验

Tong, Zhou; Fu, Guanghou; Zhou, Feng; Liu, Xiaoyan; Xue, Xing; Zhang, Hangyu; Wang, Yimin; Zhu, Xudong; Gao, Yang; Liu, Lulu; Bao, Xuanwen; Zheng, Yi; Fang, Weijia; Zhao, Peng; Jin, Baiye

[Construction of a prognosis forecasting model for immuno-therapy response in cancer patients by integrating routine clinical parameters and tumor mutational burden]

[整合常规临床参数和肿瘤突变负荷构建癌症患者免疫治疗反应预后预测模型]

Zhu, Xudong; Hao, Shuqiang; Cheng, Zhen; Fang, Weijia

Amplifying Anti-Tumor Immune Responses via Mitochondria-Targeting Near-Infrared Photodynamic Therapy

通过靶向线粒体的近红外光动力疗法增强抗肿瘤免疫反应

Li, Cheng-Ao; Nan, Junjie; Ye, Qingxuan; Zheng, Bingzhu; Dai, Xiaomeng; Li, Jingya; Wang, Feng; Ma, Huimin; Cheng, Yu; Ruan, Jian; Fang, Weijia; Zhao, Peng; Deng, Renren; Cen, Dong

Spatially resolved C1QC(+) macrophage-CD4(+) T cell niche in colorectal cancer microenvironment: implications for immunotherapy response.

结直肠癌微环境中空间分辨的 C1QC(+) 巨噬细胞-CD4(+) T 细胞微环境:对免疫治疗反应的影响

Zhang Hangyu, Hong Libing, Dong Zhen, Xin Shan, Lin Bo, Cheng Jinlin, Tian Weihong, Li Bin, Wang Jing, Liu Xiaoyan, Liu Chuan, Jin Yuzhi, Feng Yanzhi, Su Ge, Sun Xuqi, Liu Qiqi, Dai Xiaomeng, Gao Yang, Tong Zhou, Liu Lulu, Zhu Xudong, Zheng Yi, Zhao Peng, Guo Tiannan, Fang Weijia, Bao Xuanwen

Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8(+) T cell activation in patients with advanced colorectal cancer.

腹腔内输注 NKG2D CAR-NK 细胞可诱导晚期结直肠癌患者体内内源性 CD8(+) T 细胞活化

Li Bin, Zhu Xudong, Ge Jingyu, Zhang Hangyu, Gao Yang, Bao Xuanwen, Dai Xiaomeng, Du Zhicheng, Tu Xiaoxuan, Tong Zhou, Fu Qihan, Hu Dongxue, Tian Weihong, Zheng Yi, Liu Lulu, Zhao Peng, Fang Weijia, Wang Shu, Wang Dongrui

Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma

serplulimab联合贝伐珠单抗生物类似药HLX04一线治疗晚期肝细胞癌的II期研究

Ren, Zhenggang; Shao, Guoliang; Shen, Jie; Zhang, Li; Zhu, Xu; Fang, Weijia; Sun, Guoping; Bai, Yuxian; Wu, Jianbing; Liu, Lianxin; Yuan, Yuan; Zhang, Jingdong; Li, Zhen; Zhang, Ling; Yin, Tao; Wu, Jincai; Hou, Xiaoli; Yu, Haoyu; Li, Jing; Wang, Qingyu; Zhu, Jun; Fan, Jia